Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0002038798-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 2, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
234,999
Total Value
$7,751,725.34
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Exercise/Conversion | 78,333 | $27.46 | $2,151,024.18 | 78,333 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 21,306 | $69.53 | $1,481,406.18 | 57,027 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 19,656 | $70.61 | $1,387,910.16 | 37,371 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 8,777 | $71.56 | $628,082.12 | 28,594 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 12,777 | $72.94 | $931,954.38 | 15,817 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 10,358 | $73.74 | $763,798.92 | 5,459 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 5,059 | $74.60 | $377,401.40 | 400 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 400 | $75.37 | $30,148.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 1, 2026 | Exercise/Conversion | 78,333 | $0.00 | $0.00 | 321,667 | Direct | โ | View Details |